Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leafio is a leading Australian medicinal cannabis wholesaler and distributor, operating as the wholesale arm of the healthcare technology group Montu. Established in 2023, the company manages a sophisticated nationwide supply chain that connects over 100 global and local cannabis brands to a network of more than 4,000 pharmacies across Australia. Leafio focuses on a "pharmacy-first" approach, providing rapid delivery, clinical education, and regulatory support to healthcare professionals and pharmacists. In late 2025, the company solidified its market position through a major strategic distribution partnership with Aurora Cannabis and its subsidiary MedReleaf Australia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leafio.